Drawing for APTITUDE

USPTO serial 97286257

APTITUDE

Reviewed by CopyMark Law Group

Reg. 8403031Status 700Registered
Filing date
Status date
Registration date
Aug 18, 2026
Examiner
HESIK, APRIL ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with APTITUDE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Enshan Hong

Enshan Hong LAW293 Eisenhower PKWY, Suite 135Livingston, NJ 07039United States

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic preparations for medical purposes; diagnostic agents for medical purposes; diagnostic substances for medical purposes; chemical and biological agents, preparations, and substances for analyte detection in specimens for medical purposes; nucleic acid-based pharmaceutical preparations for the treatment of health diseases and conditions, in particular, identifying the presence, absence, and quantity of particular nucleic acids, proteins, organisms, or other analytes of interest, in order to test for the presence of one or more pathogens or contaminants in an infectious disease sample, such as Covid-19, influenza, respiratory syncytial virus, strep throat, sexually transmitted infectionACTIVEOct 13, 2023
009downloadable or recorded software, namely, sample preparation and analysis software for clinical research and medical uses; sample preparation device for clinical research use in the nature of a disposable sample collector component acting as a tube, and an optional disposable sample swab, sponge or wand to facilitate the collection of saliva, urine, blood, sputum, feces, semen, and other bodily fluids and tissues, or other biological samples that are easy to obtain by contacting an affected area, such as throat, nasal, nasopharyngeal, vaginal, and superficial wound cultures; sample analysis devices, namely, a cartridge that analyzes biological samples for clinical research use; kits comprised of sample collection devices and sample preparation devices for clinical research use in the nature of a cartridge, a disposable sample collector component acting as a tube, and an optional disposable sample swab, sponge or wand to facilitate the collection of saliva, urine, blood, sputum, feces, semen, other bodily fluids and tissues, or other biological samples that are easy to obtain by contacting an affected area, such as throat, nasal, nasopharyngeal, vaginal, and superficial wound cultures; analyte detection systems for clinical research use, comprising downloadable or recorded sample preparation and analysis software and sample preparation and analysis devices, namely, cartridges and sample collectors, sold as a unit; an analyte detection system for clinical research use, comprising downloadable or recorded sample preparation and analysis software, sample collection device, a sample preparation device, a sample analysis device, namely, cartridges and sample collectors, sold as a unit; downloadable or recorded software for health diagnostic testing device for identifying the presence, absence, and/or quantity of particular nucleic acids, proteins, organism, or other analytes of interest, for example, in order to test for the presence of one or more pathogens or contaminants in a sample; downloadable computer application software for mobile phones and handheld computers for use by patients for recording, logging, tracking, analyzing, and reviewing medical conditions, symptoms, ailments and asymptomatic conditions; downloadable computer application software for mobile phones and handheld computers for use by patients for viewing informational videos and accessing information in connection with recorded medical conditions, symptoms, ailments and asymptomatic conditions; downloadable computer software for mobile phones and handheld computers for use by patients for viewing historically recorded medical conditions, symptoms, ailments and asymptomatic conditions; downloadable computer application software for mobile phones and handheld computers for use by patients for receiving and reviewing medical messages and notifications from medical service providers; wireless communication devices for wireless transmission of medical data and information; downloadable computer software for use by healthcare professionals in registering patients, accessing patient information, entering and viewing patient data and records, analyzing and interpreting patient medical information, managing patient profiles, processing billing, reviewing healthcare insurance information, obtaining customer support services, tracking medical devices used by patients, and managing medical device and supply inventoryACTIVEJun 1, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 18, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 24, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jul 24, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 23, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 10, 2026IUAFUSE AMENDMENT FILED—
Jul 10, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 4, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 4, 2025EX5GSOU EXTENSION 5 GRANTED—
Nov 19, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 18, 2025EXT5SOU EXTENSION 5 FILED—
Jul 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 7, 2025EX4GSOU EXTENSION 4 GRANTED—
Jun 23, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 22, 2025EXT4SOU EXTENSION 4 FILED—
Feb 25, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 25, 2025EX3GSOU EXTENSION 3 GRANTED—
Jan 27, 2025EXT3SOU EXTENSION 3 FILED—
Jan 27, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 12, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 12, 2024EX2GSOU EXTENSION 2 GRANTED—
Jul 12, 2024EXT2SOU EXTENSION 2 FILED—
Jul 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 16, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 12, 2024EX1GSOU EXTENSION 1 GRANTED—
Jan 12, 2024EXT1SOU EXTENSION 1 FILED—
Jan 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 11, 2024NOACCORRECTED NOA E-MAILED—
Jan 10, 2024DPCCDIVISIONAL PROCESSING COMPLETE—
Nov 9, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 8, 2023INCDITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST—
Oct 30, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 17, 2023DRRRDIVISIONAL REQUEST RECEIVED—
Oct 17, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Aug 1, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 6, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 1, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 1, 2023XAECEXAMINER'S AMENDMENT ENTERED—
May 1, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 1, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
May 1, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 16, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 18, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 18, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 18, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 18, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 7, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 6, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 6, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 14, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 9, 2022DOCKASSIGNED TO EXAMINER—
Mar 3, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—

Frequently asked questions

Related guidance